Fenofibrato Mylan

Fenofibrate (Nanonised) is a medication used to manage cholesterol and triglyceride levels. This oral medication helps improve lipid profiles, supporting cardiovascular health.

Fenofibrate (Nanonised) is primarily used to lower triglyceride levels and increase HDL (good cholesterol) in the blood. It is often prescribed for individuals with high cholesterol or mixed dyslipidemia. This medication works by activating enzymes that help break down fats in the blood, promoting better lipid balance.

Common effects of Fenofibrate (Nanonised) may include gastrointestinal discomfort, such as nausea or diarrhea. Some users might experience muscle pain or weakness. These effects vary and are not experienced by everyone.

Fenofibrate (Nanonised) should be used with caution in individuals with liver or kidney disease. Regular monitoring of liver function may be advised. It is important to follow the advice of a healthcare provider regarding its use.

Fenofibrate (Nanonised) may interact with certain medications, including blood thinners and other cholesterol-lowering drugs. Alcohol consumption should be moderated, as it can affect liver function. Always consult a healthcare provider before combining medications.